Protagonist Therapeutics (PTGX) Research & Development (2015 - 2026)
Protagonist Therapeutics (PTGX) recorded Research & Development of $42.06 million in Q2 2026, up 13.6% from $37.04 million a year earlier but down 10.0% from the prior quarter.
Powered by 
Analysis
Protagonist Therapeutics (PTGX) Research & Development (2015 - 2026) Analysis & Trends
On a TTM basis, Protagonist Therapeutics' Research & Development came in at $175.16 million as of Jun 30, 2026, up 21.8% year-over-year; for FY2025, it came in at $159.29 million, up 15.3% from FY2024.
- Annual Research & Development has a five-year compound annual growth rate of 16.4% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $138.13 million in FY2024 (+15.0%), $120.16 million in FY2023 (-4.8%), $126.22 million in FY2022 (+0.2%) and $126.01 million in FY2021 (+69.1%).
- Quarterly Research & Development has ranged from $25.4 million in Q3 2022 to $46.74 million in Q1 2026 over the past five years.
- On a year-over-year basis, Research & Development has increased for ten consecutive quarters, with growth averaging 17.8% over the last eight quarters.
- Peak year-over-year performance for Research & Development in the last five years was growth of 131.0% in Q3 2021, against a decline of 31.3% in Q3 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $46.74 million (Q1 2026), $46.36 million (Q4 2025) and $40 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Protagonist Therapeutics | 9.21 Bn | 9.21 Bn | - | 42.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.06 Mn |
| Mar 31, 2026 | 46.74 Mn |
| Dec 31, 2025 | 46.36 Mn |
| Sep 30, 2025 | 40.00 Mn |
| Jun 30, 2025 | 37.04 Mn |
| Mar 31, 2025 | 35.89 Mn |
| Dec 31, 2024 | 34.90 Mn |
| Sep 30, 2024 | 35.97 Mn |
| Jun 30, 2024 | 33.52 Mn |
| Mar 31, 2024 | 33.73 Mn |
| Dec 31, 2023 | 28.90 Mn |
| Sep 30, 2023 | 30.66 Mn |
| Jun 30, 2023 | 33.18 Mn |
| Mar 31, 2023 | 27.42 Mn |
| Dec 31, 2022 | 29.88 Mn |
| Sep 30, 2022 | 25.40 Mn |
| Jun 30, 2022 | 34.61 Mn |
| Mar 31, 2022 | 36.32 Mn |
| Dec 31, 2021 | 38.37 Mn |
| Sep 30, 2021 | 36.96 Mn |
API Access
Protagonist Therapeutics Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=PTGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "PTGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=PTGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();